Galmed Pharmaceuticals Announces the Commencement of Patient Screening in the ARREST Study in the United States and Latin America, and Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Galmed Pharmaceuticals Announces the Commencement of Patient Screening in the ARREST Study in the United States and Latin America, and Reports Second Quarter 2015 Financial Results

Galmed Pharma (GLMD) Tops Q2 EPS by 4c

August 13, 2015 7:49 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More